Diagnosing Incontinence and Pelvic Floor Problems: An Efficient, Cost-Effective Approach for Primary Care Providers

  • Pater L. Rosenblatt
  • Eman Elkadry


Primary care clinicians often wonder whether they should be involved in the evaluation and management of urogynecologic issues, such as urinary and fecal incontinence, voiding dysfunction, and pelvic organ prolapse. Referring patients with urogynecologic complaints to specialists such as urogynecologists or urologists is certainly an option for those clinicians who are unfamiliar with the evaluation and management of these problems. As will be covered in this chapter, however, a basic evaluation including a directed history and physical, combined with a few simple tests, is all that is required in most patients in order to arrive at a presumptive diagnosis and initiate a well-structured, conservative treatment plan.


Urinary Incontinence Pelvic Organ Prolapse Fecal Incontinence Overactive Bladder Stress Incontinence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Burgio K, Matthews KA, Engel BT. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol. 1991;146:1255–1259.PubMedGoogle Scholar
  2. 2.
    Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc. 1990;38:273–281.PubMedGoogle Scholar
  3. 3.
    Division of Chronic Disease Control and Community Intervention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control. Urinary incontinence among hospitalized persons aged 65 years and older: United States, 1984-1987. MMWR Morb Mortal Wkly Rep. 1991;40:433–436.Google Scholar
  4. 4.
    Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995-2050. U.S. Bureau of the Census, Current Population Reports, P25-1130. Washington, D.C.: U.S. Government Printing Office. 1996.Google Scholar
  5. 5.
    Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–336.PubMedGoogle Scholar
  6. 6.
    Sirls LT, Zimmern PE, Leach GE. Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol. 1994;151:946–950.PubMedGoogle Scholar
  7. 7.
    Blaivas JG, Barbalias GA. Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J Urol. 1984;131:91–94.PubMedGoogle Scholar
  8. 8.
    McGuire EJ, Savastano JA. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction. J Urol. 984;132:713–715.Google Scholar
  9. 9.
    Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol. 2004; 190:345–350.PubMedCrossRefGoogle Scholar
  10. 10.
    Jackson SL, Weber AM, Hull TL, Mitchinson AR, Walters MD. Fecal incontinence in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 1997;89:423–427.PubMedCrossRefGoogle Scholar
  11. 11.
    Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affl iction. Am J Gastroenterol. 1996;91:33–36.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  • Pater L. Rosenblatt
  • Eman Elkadry

There are no affiliations available

Personalised recommendations